Internal Medicine, Medical Oncology · Albany, NY
NPI
1720174055
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
400 Patroon Creek Blvd, Suite 1
Albany, NY, 12206
Phone (518) 489-0044
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.2M
68,247 services
Medicare patients, 2024
430
Average age 75
Drug cost, 2024
$1.1M
517 prescriptions
Company payments, 2025
$197K
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Maria Theodoulou was code J1453 (injection, fosaprepitant, 1 mg), 8,250 times for 13 patients. In total Maria Theodoulou billed 68,247 services in 161 codes, and Medicare paid $1.2M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-03-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1453 Injection, fosaprepitant, 1 mg | Office | 8,250 | 13 | $0.11 | $867 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 962 | 22 | $0.09 | $82.84 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 700 | 17 | $0.67 | $466 |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 610 | 11 | $0.26 | $157 |
| 85025 Blood Count | Office | 582 | 272 | $7.60 | $4,422 |
| 80053 Clinical Chemistry | Office | 567 | 268 | $10.33 | $5,859 |
| 36415 Venipuncture Blood Collection | Office | 564 | 265 | $8.65 | $4,877 |
| 99214 Office E&M - Established | Office | 290 | 194 | $89.63 | $26K |
| 86300 Immunoassay | Office | 245 | 121 | $20.29 | $4,970 |
| 82378 Clinical Chemistry | Office | 241 | 126 | $18.44 | $4,443 |
| 96375 Injection Administration | Office | 237 | 30 | $12.59 | $2,984 |
| 96367 Intravenous Infusion, Hydration | Office | 157 | 25 | $23.14 | $3,632 |
| 96413 Chemotherapy Administration | Office | 155 | 39 | $106.21 | $16K |
| 82784 Immunoassay | Office | 130 | 34 | $9.11 | $1,185 |
| 99213 Office E&M - Established | Office | 119 | 97 | $70.32 | $8,368 |
By year: 2022 $932K for 56,286 services; 2023 $978K for 60,543 services; 2024 $1.2M for 68,247 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 582 | 272 | $7.60 | $4,422 |
| 80053 Clinical Chemistry | 567 | 268 | $10.33 | $5,859 |
| 36415 Venipuncture Blood Collection | 564 | 265 | $8.65 | $4,877 |
| 86300 Immunoassay | 245 | 121 | $20.29 | $4,970 |
| 82378 Clinical Chemistry | 241 | 126 | $18.44 | $4,443 |
| 82784 Immunoassay | 130 | 34 | $9.11 | $1,185 |
| 84443 Clinical Chemistry | 102 | 82 | $16.46 | $1,679 |
| 82728 Clinical Chemistry | 83 | 61 | $13.36 | $1,109 |
| 83520 Immunoassay | 72 | 30 | $16.93 | $1,219 |
| 83540 Clinical Chemistry | 66 | 54 | $6.34 | $418 |
Medicare prescription drug claims, 2024
In 2024, the drug Maria Theodoulou prescribed most often to Medicare patients was Anastrozole, with 223 prescriptions and refills. In total Maria Theodoulou wrote 517 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 223 | 507 | 77 | $3,461 |
| Letrozole Generic | 45 | 109 | 14 | $735 |
| Exemestane Generic | 38 | 76 | 14 | $7,157 |
| Orserdu Elacestrant Hcl | 22 | 22 | Under 11 | $499K |
| Ibrance Palbociclib | 21 | 21 | Under 11 | $297K |
| Olanzapine Generic | 15 | 15 | Under 11 | $62.67 |
| Prochlorperazine Maleate Generic | 14 | 14 | Under 11 | $106 |
| Tamoxifen Citrate Generic | 14 | 36 | Under 11 | $229 |
| Verzenio Abemaciclib | 13 | 13 | Under 11 | $186K |
| Leucovorin Calcium Generic | 12 | 12 | Under 11 | $493 |
Brand drugs: 72 claims; generic drugs: 445 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Maria Theodoulou $197K ($197K in general payments such as food, travel and fees) from 7 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $87K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.